JPH0368865A - Inspection of pathological tissue and dehydrating agent therefor - Google Patents

Inspection of pathological tissue and dehydrating agent therefor

Info

Publication number
JPH0368865A
JPH0368865A JP20534389A JP20534389A JPH0368865A JP H0368865 A JPH0368865 A JP H0368865A JP 20534389 A JP20534389 A JP 20534389A JP 20534389 A JP20534389 A JP 20534389A JP H0368865 A JPH0368865 A JP H0368865A
Authority
JP
Japan
Prior art keywords
dehydration
tissue
pathological
orthoacetate
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP20534389A
Other languages
Japanese (ja)
Other versions
JP2798431B2 (en
Inventor
Tsukasa Iwadare
岩垂 司
Shoji Hojo
北條 昭次
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sakura Seiki Co Ltd
Original Assignee
Sakura Seiki Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sakura Seiki Co Ltd filed Critical Sakura Seiki Co Ltd
Priority to JP20534389A priority Critical patent/JP2798431B2/en
Publication of JPH0368865A publication Critical patent/JPH0368865A/en
Application granted granted Critical
Publication of JP2798431B2 publication Critical patent/JP2798431B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

PURPOSE:To perform dehydration approximately completely, to make it possible to perform delipidation and embedding thereafter in a short time and to shorten the inspecting time by performing the dehydration under the presence of specified chemical dehydration agent. CONSTITUTION:An extracted tissue undergoes fixation, dehydration and embedding. Thereafter, the tissue is cut thinly and colored. Then the tissue is inspected with a microscope. The purpose of the dehydration is to remove water which is not soluble by paraffin out of the tissue in order to ensure the permeation of the paraffin which is the necessary condition for cutting the pathological tissue sample. The dehydration is performed under the presence of at least one kind of chemical dehydrating agent which is selected among 2, 2 dimethoxypropane, ethyl orthoformate, methyl orthoacetate and ethyl orthoacetate.

Description

【発明の詳細な説明】 〔発明の1″r景〕 く技術分野〉 本発明は病理組織標本を質的に向上させ、かつ脱水処理
時間を短縮することができる病理組織の検査方法および
それに用いる脱水処理剤に関する。
[Detailed Description of the Invention] [1''r View of the Invention] Technical Field> The present invention provides a method for examining pathological tissue that can qualitatively improve the quality of pathological tissue specimens and shorten the dehydration time, and a method used therefor. Regarding dehydration treatment agents.

〈従来技術〉 生体から採取された検体を病理組織の検査にf共するに
当っては、該検体が生体であるか死体であるかを問わず
、そのm織または臓器の構成要素である細胞を出来るだ
けありのままの姿で形態親察を行い、適確な病的所見や
診断を下すことができるように、その標本を作製する過
Uに於いて組織形態の人為的な変化を可能な限り避けな
ければならない。
<Prior art> When a specimen collected from a living body is subjected to a pathological histopathological examination, regardless of whether the specimen is a living body or a corpse, cells that are constituents of the tissues or organs of the specimen are examined. In order to examine the morphology of the tissue in its natural state as much as possible and make accurate pathological findings and diagnoses, artificial changes in tissue morphology should be avoided as much as possible during the preparation of the specimen. Must be avoided.

したがって、このような病理組織標本は、一般的に第1
図に示す様な概略過程を経て作製されている。この各々
の処理段階は伺れも必要不nJ欠なものであり、どの段
階の処理が不十分であっても病理学的診断上の問題を生
じせしめる。特に、脱水処理に於ける完璧な遂行の如何
が病理組織標本の形態保存性及び染色性の良否を決定す
る。
Therefore, such pathological tissue specimens are generally
It is manufactured through the general process shown in the figure. Each of these processing steps is completely unnecessary, and insufficient processing at any step will cause problems in pathological diagnosis. In particular, the perfect performance of the dehydration process determines the preservation of morphology and stainability of pathological tissue specimens.

脱水処理の目的は、病理組織標本を薄く切るための必要
条件であるパラフィン浸透を確丈に戊さしめるため、パ
ラフィンと相溶性のない水を組織中より除去することに
あり、このような脱水処理は完全に近い程度に迄脱水を
実施しなければならない。
The purpose of dehydration treatment is to remove water that is incompatible with paraffin from the tissue in order to ensure paraffin penetration, which is a necessary condition for thinly slicing pathological tissue specimens. In the treatment, dehydration must be carried out to a near complete degree.

このような脱水処理に用いられる処理剤としては一般に
メタノール、エタノールなどのアルコール類が用いられ
ている。
Alcohols such as methanol and ethanol are generally used as processing agents for such dehydration processing.

アルコールによる脱水処理の原理は、組織中の水分をア
ルコールで置換(希釈)することにある。
The principle of dehydration treatment using alcohol is to replace (dilute) water in tissues with alcohol.

この方法はあくまで希釈であり、水が無くなる訳ではな
い。水とアルコールが混ざり合って平衡に達すれば、以
後どんなに時間をかけても&(I織中の水分濃度はそれ
以上低下しない。
This method is only for dilution and does not eliminate the water. Once water and alcohol mix and reach equilibrium, the water concentration in the weave will not decrease any further no matter how long it takes.

そこで、組織を別の高純度のアルコールに移して同様に
置換することが必要となる。組織中の水分濃度を、必要
とされる0、  3〜0.590までに十げるためには
、この操作を何段階にも縁り返し行う段階希釈を行なう
必要がある。
Therefore, it is necessary to transfer the tissue to another high-purity alcohol for similar substitution. In order to reduce the water concentration in the tissue to the required range of 0.3 to 0.590, it is necessary to carry out serial dilution by repeating this operation in several stages.

このため、脱水過程に於けるアルコールは5〜6tfJ
必要となり、その処理時間は脱水・中間剤処理・パラフ
ィン浸透の一連の処理面fWの中で最も大きなウェイト
を占めている。
Therefore, alcohol in the dehydration process is 5 to 6 tfJ.
The processing time occupies the largest weight in the series of processing fW of dehydration, intermediate treatment, and paraffin infiltration.

〈発明が解決しようとする課題〉 このようなアルコールによる脱水処理は、得られた病理
組織標本の収縮、硬化、ひび割れ、な形及び染色不良に
最も影響を与え、それ以後の処理にも影響があるので最
も長時間を必要としていた。
<Problem to be solved by the invention> Such dehydration treatment using alcohol has the greatest effect on shrinkage, hardening, cracking, shape, and poor staining of the obtained pathological tissue specimen, and has no effect on subsequent processing. Therefore, it required the longest time.

また得られた病理組織標本も若−1収縮ひび割れ変形が
坐じたりする場合があった。
In addition, there were cases in which the obtained pathological histological specimens showed deformation due to young-1 shrinkage cracks.

〔発明の概及〕[Summary of the invention]

く要旨〉 本発明者は上記線通に鑑みて鋭意研究を重ねた結果、脱
水処理剤として水と反応する特定な化合物を用いること
により、脱水が平衡状態に達することなく、完全に脱水
でき、しかも組織の形態保存性が良好で寸法安定性が良
好であることか1’ll明し、本発明を完成するに至っ
た。
Summary> The present inventor has conducted intensive research in view of the above-mentioned findings, and has found that by using a specific compound that reacts with water as a dehydration treatment agent, complete dehydration can be achieved without dehydration reaching an equilibrium state. Moreover, it was found that the structure had good shape preservation and dimensional stability, and the present invention was completed.

すなわち、本発明の病理組織の検査方法は、摘出した組
織を、固定処理、脱水処理、脱脂処理および包埋処理し
た後、それを薄く切って染色して顕微鏡で検査する病理
組織の検査方法において、前記脱水処理を2,2−ジメ
トキシプロパン、オルソ蟻酸メチル、オルソ蟻酸エチル
、オルソ酢酸メチル、オルソ酢酸エチルから選ばれた少
なくとも一種の化学的脱水剤の存(1゛下に行なうこと
、を特徴とする方法である。
That is, the method for examining pathological tissue of the present invention includes fixing, dehydrating, degreasing, and embedding the extracted tissue, and then cutting it into thin slices, staining the tissue, and examining it under a microscope. , the dehydration treatment is carried out in the presence of at least one chemical dehydrating agent selected from 2,2-dimethoxypropane, methyl orthoformate, ethyl orthoformate, methyl orthoacetate, and ethyl orthoacetate. This is the method to do so.

また、本発明の病理組織の検査に用いる脱水処理剤とし
ては、2,2−ジメトキシプロパン、オルソ蟻酸メチル
、オルソ蟻酸エチル、オルソ酢酸メチル、オルソ酢酸エ
チルから選ばれた少なくとも一種の化学的脱水剤を含有
すること、を特徴とするものである。
The dehydrating agent used in the examination of pathological tissues of the present invention is at least one chemical dehydrating agent selected from 2,2-dimethoxypropane, methyl orthoformate, ethyl orthoformate, methyl orthoacetate, and ethyl orthoacetate. It is characterized by containing.

〈効果〉 本発明の脱水処理剤を用いた病理組織の検査方法は、2
.2−ジメトキシプロパンを例として説明すると、これ
が組織中の水と反応してアセトンとメタノールに変化す
るので、反応した途端に水か存在しなくなるので水とア
ルコールとが柑甲?7iによってそれ以上脱水が進まな
くなるといったことがない。
<Effect> The method for examining pathological tissue using the dehydration treatment agent of the present invention is as follows:
.. Taking 2-dimethoxypropane as an example, it reacts with water in the tissue and changes into acetone and methanol, so as soon as the reaction occurs, water ceases to exist, so water and alcohol are called citrus? 7i does not prevent dehydration from progressing any further.

また、生成したアセトンやメタノールは従来から脱水剤
としてこの目的に使用されてきたものであり、これらの
生成は脱水に対して悪い影響を及ぼすことはない。
Furthermore, the produced acetone and methanol have conventionally been used as dehydrating agents for this purpose, and their production does not have a negative effect on dehydration.

よって、本発明の化学的脱水剤を用いた組織の脱水方法
は、従来のアルコールによる脱水処理に比べて処理11
11間が著しく、通常1/3程度にまで短縮されるので
脱水槽が1槽で済む。
Therefore, the tissue dehydration method using the chemical dehydrating agent of the present invention is more effective than the conventional dehydration treatment using alcohol.
Since the time required for dehydration is reduced to approximately 1/3, only one dehydration tank is required.

更に、脱水処理がほぼ完全に行なわれるので、その後の
脱脂処理および包埋処理が短時間で行なうことができる
ので、検査時間を著るしく短縮することができる。
Furthermore, since the dehydration treatment is almost complete, the subsequent degreasing treatment and embedding treatment can be carried out in a short time, so that the inspection time can be significantly shortened.

また、はぼ完全に脱水ができるので、組織の収縮、硬化
、ひび割れ、変形及び染色性不良などが無く、組織の形
態保イj性が良好で、寸法安定性の良い質的に優れた病
理組織標本を得ることかできる。
In addition, since it can be completely dehydrated, there is no tissue shrinkage, hardening, cracking, deformation, or poor staining, and the tissue has good shape retention and dimensional stability, making it a qualitatively superior pathology. Tissue specimens can be obtained.

これによって、適確な病的所見や診断を下すことができ
る。
This allows accurate pathological findings and diagnosis to be made.

〔発明の詳細な説明〕[Detailed description of the invention]

〔I〕病理組織の検査方法 本発明における病理組織の検査は、摘出した組織を、固
定処理、脱水処理、脱脂処理および包埋処理した後、そ
れを薄く切って染色して顕微鏡で検査することによって
行なわれるが、上記脱水処理工程において、2,2−ジ
メトキシプロパン、オルソ蟻酸メチル、オルソ蟻酸エチ
ル、オルソ酢酸メチル、オルソ酢酸エチルから選ばれた
少なくとも一種の化学的脱水剤の存在下に行なうことが
重要である。
[I] Pathological tissue inspection method The pathological tissue inspection in the present invention involves fixing, dehydrating, degreasing, and embedding the extracted tissue, and then cutting it into thin slices, staining them, and inspecting them under a microscope. The dehydration step is carried out in the presence of at least one chemical dehydrating agent selected from 2,2-dimethoxypropane, methyl orthoformate, ethyl orthoformate, methyl orthoacetate, and ethyl orthoacetate. is important.

(1)固定処理 固定処理の主たる目的は、組織・細胞の自家融解(主に
、これらの中心的構成成分である蛋白質の変質)を防止
することにあり、該処理剤として一般的にホルマリン水
溶液等の化学的固定剤溶液が用いられる。
(1) Fixation treatment The main purpose of fixation treatment is to prevent autologous lysis of tissues and cells (mainly denaturation of proteins, which are their central components), and formalin aqueous solution is generally used as the treatment agent. A chemical fixative solution such as

このような処理剤は(イ)自家融解があまり進行しない
うちに組織塊の中心部までIIJ能な眠り速やかに固定
剤溶液が浸透すること、及び(ロ)そこで固′T:剤と
蛋白質とか化学反応し蛋白質のそれ以後の段階での変質
を防ぐことの二つの条件が’t&足されることが重要で
ある。
Such a processing agent has the following properties: (a) the fixative solution quickly penetrates into the center of the tissue mass before autolysis progresses too much, and (b) the fixative solution quickly penetrates into the center of the tissue mass before autolysis progresses too much, and (b) the fixative solution penetrates into the center of the tissue mass before autolysis progresses too much. It is important that the two conditions of chemical reaction and prevention of protein denaturation in subsequent stages are met.

摘出された組織は固定剤溶液を浸透させるため篭などに
入れられて固定剤溶液を収容する積山に入れて固定剤溶
液中に浸漬される。このd請は一般に15〜25℃の温
度で数時間〜数11程度行なわれる。
The excised tissue is placed in a basket or the like to allow the fixative solution to permeate therein, and then placed in a stack containing the fixative solution and immersed in the fixative solution. This process is generally carried out at a temperature of 15 to 25°C for several hours to several dozen hours.

このような固定処理が不十分な場合には、組織各部の形
態保存が不良となり、且つ溶血・染り性不良等をも引き
起こして、病理診断上組人な支障をきたす。
If such fixation is insufficient, the shape preservation of each part of the tissue will be poor, and it will also cause hemolysis, poor staining, etc., which will cause problems in pathological diagnosis.

(2)脱水処理 脱水処理の目的は、病理組織標本を薄く切るための必要
条件であるパラフィン浸透を確実に成さしめるため、パ
ラフィンと相溶性のない7gを組織中より除虫すること
にあり、このような脱水処理は完全に近い程度に迄脱水
を丈施しなければならない。
(2) Dehydration treatment The purpose of dehydration treatment is to remove 7g of insects that are incompatible with paraffin from the tissue in order to ensure paraffin penetration, which is a necessary condition for thinly slicing pathological tissue specimens. In such a dehydration process, dehydration must be carried out to a nearly complete degree.

このような脱水処理が不十分であると、組織の収縮・硬
化・ひび割れ・変形、及び染色性不良等が生じ、診断に
支障をきたす。
If such dehydration treatment is insufficient, tissue shrinkage, hardening, cracking, deformation, poor staining, etc. will occur, which will impede diagnosis.

このような脱水処理に用いられる薬剤としては、従来、
メタノール、エタノールなどのアルコール項を用いるの
が一般的であるが、本発明においては2,2−ジメトキ
シプロパン、オルソ蟻酸メチル、オルソ蟻酸エチル、オ
ルソ酢酸メチル、オルソ酢酸エチルから選ばれた少なく
とも一種の化学的脱水剤を含有する後記脱水処理剤を用
いることが重要である。
Conventionally, the chemicals used for this type of dehydration treatment include
Although alcohols such as methanol and ethanol are generally used, in the present invention, at least one alcohol selected from 2,2-dimethoxypropane, methyl orthoformate, ethyl orthoformate, methyl orthoacetate, and ethyl orthoacetate is used. It is important to use a dehydration treatment agent described below that contains a chemical dehydration agent.

(3)脱脂処理および包埋処理 脱脂処理、包埋処理の各段階に於いては、組織中に存在
するその前段階での溶媒および脂肪をキシレンまたはク
ロロホルムなどの処理岐にて置換し、更にパラフィンで
処理して最終的に組織の中にパラフィンを十分浸透させ
て包埋することを目的としている。
(3) Degreasing and embedding treatment At each stage of degreasing and embedding, the solvent and fat present in the tissue in the previous stage are replaced with a treatment branch such as xylene or chloroform, and The purpose is to process the tissue with paraffin and finally allow the paraffin to penetrate sufficiently into the tissue for embedding.

(4)薄切、染色および鏡検 上記パラフィン包埋した病理組織標本を通゛11:i;
2〜5μmの厚さに薄く切って、病理検査の目的に応じ
た染色法により染色して、これを顕微鏡により拡大して
癌組織などの異常が存在するか否かを検査する。
(4) Thin sectioning, staining, and microscopic examination of the above paraffin-embedded pathological tissue specimen.11:i;
It is cut into thin slices with a thickness of 2 to 5 μm, stained using a staining method depending on the purpose of the pathological examination, and enlarged with a microscope to examine whether abnormalities such as cancerous tissue are present.

(5)処理槽 前記固定処理ないし包埋処理は、一般にそれぞれ異なる
槽に病理組織を浸漬することによって行なわれる。
(5) Processing tanks The above-mentioned fixation treatment or embedding process is generally performed by immersing the pathological tissue in different tanks.

これら処理槽は各段階の処理液の浸透を確実に行なうた
め、同一の液を何槽か配置する(例えば、アルコール槽
を5槽配置するなど)という方法で処理槽の数が決めら
れる。これら処理槽は[11を1[構成するように配置
され、その中央部にリフト装置が設置されている。該リ
フト装置には篭が冶の数だけ吊り下げられており、該篭
中に病理組織を入れてこの篭を上げ下げしながら一定時
間毎に少しづつ回動させて順次各処理積山のiflに篭
を浸漬する。
In order to ensure that the processing liquid at each stage permeates through these processing tanks, the number of processing tanks is determined by arranging several tanks containing the same liquid (for example, five alcohol tanks are arranged). These processing tanks are arranged so as to constitute [11], and a lift device is installed in the center thereof. A number of baskets are suspended from the lift device, and the pathological tissues are placed in the baskets, and the baskets are raised and lowered and rotated little by little at regular intervals, so that the baskets are placed one after another in each processing pile. Soak.

一般に固定処理では1槽、脱水処理では5〜6槽、脱脂
処理では2〜3槽、包埋処理では3〜4槽であるが、本
発明の脱水処理剤を用いれば脱水処理は1漕で十分であ
る。
Generally, fixation treatment requires 1 tank, dehydration treatment requires 5 to 6 tanks, degreasing treatment requires 2 to 3 tanks, and embedding treatment requires 3 to 4 tanks, but if the dehydration treatment agent of the present invention is used, dehydration treatment can be performed in 1 tank. It is enough.

また、本発明では脱水処理が十分に行なわれるので、そ
の後の処理も容易に(テなわれやすくなるので脱脂処理
および包埋処理の檜の数を1冶および3槽と少なくする
ことができる。
Further, in the present invention, since the dehydration treatment is sufficiently performed, the subsequent treatment is also easy (because the cypress is easily damaged, the number of cypresses to be degreased and embedded can be reduced to 1 and 3 tanks).

よって検査時間を著しく短縮することができる。Therefore, inspection time can be significantly shortened.

(II)脱水処理剤 本発明において用いられる脱水処理剤としては、2.2
−ジメトキシプロパン(以下単にrDMPJと略記する
ことがある。)、オルソ蟻酸メチル、オルソ蟻酸エチル
、オルソ酢酸メチル、オルソ酢酸エチルから選ばれた少
なくとも一種の化学的脱水剤を含有するものが用いられ
る。
(II) Dehydration agent The dehydration agent used in the present invention includes 2.2
- One containing at least one chemical dehydrating agent selected from dimethoxypropane (hereinafter sometimes simply abbreviated as rDMPJ), methyl orthoformate, ethyl orthoformate, methyl orthoacetate, and ethyl orthoacetate is used.

このうち2,2−ジメトキシプロパンを利にとわされる
もので、分子m104.15、比重d20−0.847
、沸点83℃の物理的性質を示し、条件下で、下記式で
示されるように水と反応してアセトンとメタノールに変
化する。つまり、存圧する水を分解してしまうと共に、
自らも異なった物質に変化する。したがって、DMPの
脱水はDMPと水との化学的反応であることから反応し
た途端に水そのものが無くなってしまうことか本発明の
脱水処理剤の特徴である。
Of these, 2,2-dimethoxypropane is used, with a molecule m104.15 and a specific gravity d20-0.847.
It exhibits physical properties with a boiling point of 83°C, and under certain conditions, it reacts with water and changes into acetone and methanol as shown in the following formula. In other words, as well as decomposing the water under pressure,
It also transforms itself into a different substance. Therefore, since the dehydration of DMP is a chemical reaction between DMP and water, the dehydration treatment agent of the present invention is characterized by the fact that the water itself disappears as soon as the reaction occurs.

CHOCH3CH3 DMP1分子   水1分子 アセトン1分子 メタノ
ール2分子上記DMPと水の反応には、酸濃度が大きく
関与する。酸濃度が高い程、反応が速く進む。従って、
酸を必要ユ加えることは極めて重要であり、酸が不足で
あれば反応が遅くなったり、全く反応が起きないことに
なる。
CHOCH3CH3 1 molecule of DMP 1 molecule of water 1 molecule of acetone 2 molecules of methanol The acid concentration is greatly involved in the above reaction between DMP and water. The higher the acid concentration, the faster the reaction will proceed. Therefore,
Adding the necessary amount of acid is extremely important; if there is not enough acid, the reaction will be slow or will not occur at all.

上記DMPに配合される酸としては、一般に塩酸、パラ
トルエンスルホン酸、蓚酸などが用いられるが、これら
の中では塩酸または蓚酸を用いるのが好ましい。
As the acid blended in the DMP, hydrochloric acid, para-toluenesulfonic acid, oxalic acid, etc. are generally used, and among these, it is preferable to use hydrochloric acid or oxalic acid.

脱水を行なうためには上記反応式から分かる様に、理論
的には1モルの水を分解するのに簀モル量のDMPを必
要とするが、実際に脱水を行う14合には、余裕が必要
となり、この計算量の1.2倍モル程度以上の量で用い
ることが必要である。
In order to perform dehydration, as can be seen from the above reaction formula, theoretically, a mol amount of DMP is required to decompose 1 mol of water, but in actual dehydration, there is a margin. Therefore, it is necessary to use an amount of about 1.2 times the calculated amount by mole or more.

DMPを計算量の1.5倍量で用いた場へ、脱水処理後
の液は、アセトン・メタノール・D M Pがほぼ1:
1:1の等瓜混合液(重量比)となる。
In a field where DMP was used in an amount 1.5 times the calculated amount, the liquid after dehydration was approximately 1:1: acetone, methanol, and DMP.
The result is a 1:1 melon mixture (weight ratio).

ここで、生成したアセトン及びメタノールは、従来から
生体組織の脱水に使用されてきた試薬そのものであり、
このような生成物が生成しても検査に支障がない。
Here, the acetone and methanol produced are the same reagents that have traditionally been used for dehydrating living tissues.
Even if such products are generated, there is no problem in inspection.

DMPと水との反応自体は、触媒としての酸を適切量加
えれば、水と出会った瞬間に終了してしまう。
The reaction between DMP and water itself will end the moment it encounters water if an appropriate amount of acid is added as a catalyst.

しかし、組織の脱水を行うためには、NHaの中心部ま
で脱水処理液が浸透することが重要であるので、脱水を
行なうためには適度な時間を必要とする。
However, in order to dehydrate the tissue, it is important that the dehydration treatment liquid penetrates into the center of the NHa, so a suitable amount of time is required for dehydration.

そのような浸透の時間は病理組織の種類や厚さや温度に
よって変化するが、DMPによる組織脱水の所要時間は
、厚さ3mmの組織では、加温しない場合3時間である
が、30℃に加温すれば1.5〜2時間で脱水がほぼ終
了する。
The time for such penetration varies depending on the type, thickness, and temperature of the pathological tissue, but the time required for tissue dehydration with DMP is 3 hours without heating for a tissue 3 mm thick, but when heated to 30°C, the time required for tissue dehydration is 3 hours. If heated, dehydration will be almost complete in 1.5 to 2 hours.

この結果は、エタノールの浸透速度と殆んど同じである
This result is almost the same as the permeation rate of ethanol.

一方、実際に標本の仕上がりから1′11断すると、4
0〜45℃加温の場合、DMPの脱水所出時間は組織の
厚さ5闘の場合4−5時間であるが、組織の厚さ3關の
の場合2 、 511.’j間となり、火に組織の厚さ
1m+iの場合45分となる。
On the other hand, if you actually cut 1'11 from the finish of the specimen, 4
In the case of heating from 0 to 45°C, the dehydration time of DMP is 4-5 hours when the tissue thickness is 5 mm, but when the tissue thickness is 3 mm, the dehydration time is 2.511. If the thickness of the tissue is 1 m + i, it will take 45 minutes.

(m)実験例 実施例1 サクラ精機■製真空自動固定包埋装置を使用し、下記に
示す摘出した組織を用いて、下記に示す条件で、固定処
理、脱水処理、脱脂処理および包埋処理を行なった。
(m) Experimental Example Example 1 Fixation, dehydration, degreasing, and embedding were carried out under the following conditions using Sakura Seiki's automatic vacuum fixation and embedding device, using the extracted tissue shown below. I did it.

(使用組織) 肝臓 厚さ1+nuX縦15關×横25mm肝臓 厚さ
3 mm X縦15問×横25mm肝臓 厚さ5關×縦
15mmXf!25m+*(処理条件) 固定:20%ホルマリン固定 脱水:DMP99.75重ユ% 塩酸0.25重量%(仮想pH−2,2)脱脂:クロロ
ホルム 包埋:パラフィン 上記処理液を用いて第1表に示す処理を行なった。
(Tissue used) Liver thickness 1 + nuX length 15 mm x width 25 mm Liver thickness 3 mm x length 15 questions x width 25 mm Liver thickness 5 mm x length 15 mm 25m+* (processing conditions) Fixation: 20% formalin fixation Dehydration: DMP 99.75% by weight Hydrochloric acid 0.25% by weight (virtual pH -2.2) Degreasing: Chloroform embedding: Paraffin Table 1 using the above treatment solution The process shown below was performed.

実施例2〜5 実施例1のDMPを、オルソ蟻酸メチル、オルソ蟻酸エ
チル、オルソ酢酸メチルまたはオルソ酢酸エチルに変更
した以外は実施例1の方法と同様の方法で行なった。
Examples 2 to 5 The same method as in Example 1 was conducted except that DMP in Example 1 was changed to methyl orthoformate, ethyl orthoformate, methyl orthoacetate, or ethyl orthoacetate.

その結果を第1表に示す。The results are shown in Table 1.

得られた病理組織標本は組織形態保存性および寸法安定
性も良好なものであった。
The obtained pathological tissue specimens had good tissue morphology preservation and dimensional stability.

比較例1および2 脱水処理剤にメタノールおよびエタノールを用いて第1
表に示す如き処理を行なった以外は丈施例1と同様に実
施した。
Comparative Examples 1 and 2 Using methanol and ethanol as dehydration treatment agents, the first
The same procedure as in Length Example 1 was carried out except that the treatments shown in the table were carried out.

その結果を第1表に示す。The results are shown in Table 1.

また、得られた病理組織標本はひび割れがあり、十分な
標本であるとは言い難いものであった。
In addition, the obtained pathological tissue specimen had cracks, and it was difficult to say that it was a sufficient specimen.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は本発明病理組織の検査方法において行なわれる
各種処理の順序を表わす図である。
FIG. 1 is a diagram showing the order of various processes performed in the pathological tissue inspection method of the present invention.

Claims (1)

【特許請求の範囲】 1、摘出した組織を、固定処理、脱水処理、脱脂処理お
よび包埋処理した後、それを薄く切って染色して顕微鏡
で検査する病理組織の検査方法において、前記脱水処理
を2,2−ジメトキシプロパン、オルソ蟻酸メチル、オ
ルソ蟻酸エチル、オルソ酢酸メチル、オルソ酢酸エチル
から選ばれた少なくとも一種の化学的脱水剤の存在下に
行なうことを特徴とする、病理組織の検査方法。 2、2,2−ジメトキシプロパン、オルソ蟻酸メチル、
オルソ蟻酸エチル、オルソ酢酸メチル、オルソ酢酸エチ
ルから選ばれた少なくとも一種の化学的脱水剤を含有す
ることを特徴とする、病理組織の検査に用いる脱水処理
剤。
[Scope of Claims] 1. A pathological tissue inspection method in which the extracted tissue is fixed, dehydrated, degreased, and embedded, and then cut into thin slices, stained, and examined under a microscope, wherein the dehydration treatment A method for examining pathological tissue, characterized in that the method is carried out in the presence of at least one chemical dehydrating agent selected from 2,2-dimethoxypropane, methyl orthoformate, ethyl orthoformate, methyl orthoacetate, and ethyl orthoacetate. . 2,2,2-dimethoxypropane, methyl orthoformate,
1. A dehydration treatment agent used for examination of pathological tissues, characterized by containing at least one chemical dehydration agent selected from ethyl orthoformate, methyl orthoacetate, and ethyl orthoacetate.
JP20534389A 1989-08-08 1989-08-08 Inspection method for pathological tissue and dehydrating agent used therefor Expired - Lifetime JP2798431B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP20534389A JP2798431B2 (en) 1989-08-08 1989-08-08 Inspection method for pathological tissue and dehydrating agent used therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20534389A JP2798431B2 (en) 1989-08-08 1989-08-08 Inspection method for pathological tissue and dehydrating agent used therefor

Publications (2)

Publication Number Publication Date
JPH0368865A true JPH0368865A (en) 1991-03-25
JP2798431B2 JP2798431B2 (en) 1998-09-17

Family

ID=16505325

Family Applications (1)

Application Number Title Priority Date Filing Date
JP20534389A Expired - Lifetime JP2798431B2 (en) 1989-08-08 1989-08-08 Inspection method for pathological tissue and dehydrating agent used therefor

Country Status (1)

Country Link
JP (1) JP2798431B2 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7414734B2 (en) 2005-02-25 2008-08-19 Ricoh Printing Systems, Ltd. Image position detecting device and image forming apparatus using the same
JP2008286694A (en) * 2007-05-18 2008-11-27 Shinichiro Isobe Preparation method for biological sample
JP2011059133A (en) * 2001-10-01 2011-03-24 Leica Biosystems Melbourne Pty Ltd Histological tissue specimen treatment
US8554372B2 (en) 2003-09-29 2013-10-08 Leica Biosystems Melbourne Pty Ltd System and method for histological tissue specimen processing
CN113588384A (en) * 2021-06-15 2021-11-02 北京清华长庚医院 Dehydration method of liver pathological large tissue
CN116622801A (en) * 2023-07-24 2023-08-22 安泰康生物技术(北京)有限公司 Method for detecting sensitivity of patient-derived ultramicro tissue culture medicament

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011059133A (en) * 2001-10-01 2011-03-24 Leica Biosystems Melbourne Pty Ltd Histological tissue specimen treatment
US8394322B2 (en) 2001-10-01 2013-03-12 Leica Biosystems Melbourne Pty Ltd Histological tissue specimen treatment
US8554372B2 (en) 2003-09-29 2013-10-08 Leica Biosystems Melbourne Pty Ltd System and method for histological tissue specimen processing
US7414734B2 (en) 2005-02-25 2008-08-19 Ricoh Printing Systems, Ltd. Image position detecting device and image forming apparatus using the same
JP2008286694A (en) * 2007-05-18 2008-11-27 Shinichiro Isobe Preparation method for biological sample
CN113588384A (en) * 2021-06-15 2021-11-02 北京清华长庚医院 Dehydration method of liver pathological large tissue
CN116622801A (en) * 2023-07-24 2023-08-22 安泰康生物技术(北京)有限公司 Method for detecting sensitivity of patient-derived ultramicro tissue culture medicament

Also Published As

Publication number Publication date
JP2798431B2 (en) 1998-09-17

Similar Documents

Publication Publication Date Title
Hayat Basic techniques for transmission electron microscopy
EP1644715B1 (en) Method for histoprocessing
US7666620B2 (en) Rapid tissue processing system
US4911915A (en) Method of processing tissue specimens and dehydrant solvent for use therein
US10837880B2 (en) Universal system, method and solution for the acceleration of the process of fixing, dehydrating and clearing the structure of biological tissue
JP2798430B2 (en) Pathological tissue inspection method and fixed embedding device used therefor
CN110132673B (en) Method for preparing needle mushroom fruiting body tissue slices
JPH0368865A (en) Inspection of pathological tissue and dehydrating agent therefor
JP2004506199A (en) Rapid Papanicolaou Staining of Cervical Vaginal Specimens
JP3723204B1 (en) Impermeable tissue quick fixative
Joyner et al. Immunohistochemistry of whole-mount mouse embryos
CN106644644A (en) Quick and low-toxic mosquito paraffin section manufacturing method
AU2018223002B2 (en) Tissue processing reagent
RU2420299C1 (en) Method of preparing histological preparations
CN114839020A (en) Cell pathology slide fixing solution and preparation method thereof
CN116358950A (en) Rapid dehydration and transparency method for pathological section
US9835527B2 (en) Tissue processing reagent
NL2033625B1 (en) Tissue sample preparation
CN113545337B (en) Method for sizing a mammalian heart valve
CN104663647A (en) Heart tissue fixing agent as well as preparation method and application of heart tissue fixing agent
Armstrong et al. Backprocessing paraffin wax blocks for subgross examination.
CN115791339B (en) Transparentization method of biological tissue large-volume sample
CN116046503B (en) Antigen retrieval liquid capable of enhancing specific staining effect and reducing staining background and application thereof
CN114279797A (en) Bone marrow biopsy fixing solution and preparation method thereof
Shah Comparative Study of Tissue Processing and Staining by Microwave and Routine Method